Exclusive | Lilly Agrees to Buy Trio of Vaccine Developers – WSJ

United States
  1. Exclusive | Lilly Agrees to Buy Trio of Vaccine Developers  WSJ
  2. Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals  CNBC
  3. Lilly announces three acquisitions to build infectious disease portfolio  PR Newswire
  4. LimmaTech Biologics to be Acquired by Lilly for Next-generation Vaccines Against Common Bacterial Infections  Business Wire
  5. Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion  Bloomberg.com

Leave a Comment

Your email address will not be published. Required fields are marked *